This is a informational document is about Carbapenem-resistant Acinetobacter baumannii (CRAB) by the Health and Human ...
core
Introduction: Acinetobacter baumannii, a known causative agent of nosocomial infections, is one of the highly antibiotic-resistant gram-negative bacilli. Carbapenem-resistant Acinetobacter isolates are increasingly reported worldwide. Carbapenems such as
Mojtaba Moosavian +2 more
doaj
Successful treatment of multidrug resistant Acinetobacter baumannii meningitis
Background: Acinetobacter baumannii is a major cause of nosocomial infections in many hospitals and appears to have a propensity for developing multiple antimicrobial resistance rapidly.Cases: We report two cases with post-surgical meningitis due to ...
Acinetobacter baumannii, Post-surgical meningitis, High dose meropenem
core
Clinical Impact of Biofilm-Producing Carbapenem-Resistant Acinetobacter baumannii: Diagnosis and Treatment Challenges. [PDF]
Bhati DG, Patil HV, Patil SR.
europepmc +1 more source
Linalool exhibits potent antibacterial and anti-biofilm activity against carbapenem-resistant Acinetobacter baumannii. [PDF]
Jin HW, Jung SY, Eom YB.
europepmc +1 more source
Rapid identification of carbapenem-resistant Acinetobacter baumannii based on MALDI-TOF mass spectrometry and machine learning. [PDF]
Zhou M, Zhao L, Li D, Cheng Z.
europepmc +1 more source
Characterization of carbapenem-resistant Acinetobacter baumannii in Shanghai and Hong Kong [PDF]
Chun Mei, Ying +3 more
openaire +2 more sources
A 16-Year-Old Male Patient With Severe Electrical Burns With Chronic and Recurrent Hospital-Acquired Opportunistic Infection With Carbapenem-Resistant Acinetobacter baumannii. [PDF]
Hong J, Wang S, Du J, Pan Q, Qian J.
europepmc +1 more source
Genetic characterization of tigecycline and carbapenem resistant Acinetobacter baumannii in a tertiary care hospital of Northern India. [PDF]
Chaudhary J +7 more
europepmc +1 more source
Carbapenem-resistant Acinetobacter baumannii bloodstream infections and specific phages isolation, analysis and application. [PDF]
Wang L +5 more
europepmc +1 more source

